Home/Filings/4/0000899243-23-006732
4//SEC Filing

Barry Douglas 4

Accession 0000899243-23-006732

CIK 0001819133other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:06 PM ET

Size

7.6 KB

Accession

0000899243-23-006732

Insider Transaction Report

Form 4
Period: 2023-03-01
Barry Douglas
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-01+143,391143,391 total
    Exercise: $5.20Exp: 2033-03-01Common Stock (143,391 underlying)
  • Award

    Common Stock

    2023-03-01+23,89823,898 total
Footnotes (2)
  • [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 1/3 on February 5, 2024, 1/3 on February 3, 2025 and 1/3 on February 2, 2026 subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
  • [F2]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Issuer

Tango Therapeutics, Inc.

CIK 0001819133

Entity typeother

Related Parties

1
  • filerCIK 0001890662

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:06 PM ET
Size
7.6 KB